08:00 , Mar 5, 2012 |  BioCentury  |  Finance

Putting debt to work

It's notoriously difficult for development-stage public biotechs in Asia to raise enough money to support their clinical programs. To get around the problem, Japan's NanoCarrier Co. Ltd. and Korea's CrystalGenomics Inc. have turned to debt...
01:40 , Feb 17, 2012 |  BC Extra  |  Financial News

NanoCarrier to raise $47.7 million

NanoCarrier Co. Ltd. (Tokyo:4571) is planning to raise Y3.7 billion ($47.7 million) through the sale of convertible bonds and stock options to Whiz Partners and CSK Venture Capital. The offerings are contingent on shareholder approval...